Clinical Trial Update: c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing c-CetuIRI versus second-line irinotecan in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• c-CetuIRI

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN